Influenza Vaccine Live Intranasal
Influenza Vaccine Live Intranasal · INFLUENZA B VIRUS 1000000 [FFU]/125mL; INFLUENZA A VIRUS 1000000 [FFU]/125mL · Spray · MedImmune, U.K. Limited
NDC 66020-0051-92 · 125 mL in 1 BOTTLE · DRUG FOR FURTHER PROCESSING · View full market →
Bulk ingredient — not a finished product
This NDC is a raw material (drug for further processing) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.
Medicare Part D
This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Influenza Vaccine Live Intranasal (Spray)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| MedImmune, U.K. Limited | INFLUENZA B VIRUS 1000000 [FFU]/125mL; INFLUENZA A VIRUS 1000000 [FFU]/125mL | Jul 22, 2026 | Sep 2, 2026 |
| MedImmune, LLC | INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 (H1N1) LIVE (ATTENUATED) ANTIGEN 10000000 [FFU]/.2mL; INFLUENZA A VIRUS A/DARWIN/1369/2025 (H3N2) LIVE (ATTENUATED) ANTIGEN 10000000 [FFU]/.2mL; INFLUENZA B VIRUS B/PERTH/115/2025 LIVE (ATTENUATED) ANTIGEN 10000000 [FFU]/.2mL | Jul 24, 2026 | Aug 28, 2026 |
| MedImmune, LLC | INFLUENZA A VIRUS A/NORWAY/31694/2022 (H1N1) LIVE (ATTENUATED) ANTIGEN 10000000 [FFU]/.2mL; INFLUENZA A VIRUS A/PERTH/722/2024 (H3N2) LIVE (ATTENUATED) ANTIGEN 10000000 [FFU]/.2mL; INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 LIVE (ATTENUATED) ANTIGEN 10000000 [FFU]/.2mL | Jul 15, 2026 | Jul 22, 2026 |
| MedImmune, U.K. Limited | INFLUENZA A VIRUS 1000000 [FFU]/125mL; INFLUENZA B VIRUS 1000000 [FFU]/125mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Influenza Vaccine Live Intranasal — NDC 66020-0051-92," retrieved September 3, 2026, https://drugdashboards.com/drug/66020005192.
Free to cite with attribution — see how the data is put together.